about usmain logo presentation
pipeline inthenews
technology officers
investorinfo quicklinks






A New Era in Targeted Anti-Viral Therapeutics                                         NanoViricides Recent Press Releases

Imagine coursing through the blood stream, chasing through the body, grabbing and destroying the offending virus particles. NanoViricides, Inc. is striving to bring this imagination to fruition. A nanoviricide®, as defined by the Company, is a nanomachine that is armed to destroy a particular kind of virus. Which virus? That information is programmed into the nanoviricide, akin to the postal address on an envelope.

flucide-main


Biomimetic Technology to "Fool" Viruses

A "nanoviricide" is an agent designed by the Company to fool a virus into attaching to this antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface. Once attached, the flexible nanoviricide glob wraps around the virus and traps it. In the process, the virus also loses its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. A nanoviricide completes the task of dismantling the virus particle without immune system assistance. This is the putative or designed mechanism of action of a nanoviricide. Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines), which are currently well established antiviral strategies.

A nanoviricide is large enough for a virus particle to latch onto it. Yet small enough to circulate readily in the body. Rather than the virus particle entering into a nanoviricide, a nanoviricide wraps around the virus particle and encapsulates it, by using the virus particle's very same ability to enter a cell.

 

 

NanoViricides In the News

05-15-2012 NanoViricides building Shelton lab/office/plant
NanoViricides Inc. has hired one of the world's foremost biopharma lab designers to advise it in building a state-of-the-art lab of its own in Shelton.
05-18-2012NanoViricides' antiviral lands U.S. patent
NanoViricides Inc. says it won a U.S. patent on a key component of its bioscience that enables its treatment to mimic a virus' host cell so it can chemically attack and destroy the germ.

Latest Interviews & Presentations

Eugene Seymour Interview

Eugene Seymour Interview:

RedChip Money Report

Anil Diwan Presentation

Anil Diwan Presentation:

At OneMedPlace

        

 


Dr. Diwan invented novel polymeric micelle-based nanomedicine technologies

more.....

Anil R. Diwan

Chairman & President

Dr. Seymour became a consultant to the UN Global Program on AIDS

more.....

Eugene Seymour

Chief Executive Officer

Ms. Vyas was First Indian woman to be named CEO of a publicly listed US corporation

more.....

Meeta Vyas

Chief Financial Officer

Dr. Barton has over 25 years experience in drug discovery and development

more.....

Randall Barton

Chief Scientific Officer



Contact Information

NanoViricides, Inc.
135 Wood Street, Suite 200,
West Haven CT 06516

Phone: +1-203-937-6137
Phone: +1-888-591-3579
Fax: +1-203-859-5095
E-mail: info@nanoviricides.com